Analysts Set Dianthus Therapeutics, Inc. (NASDAQ:DNTH) Price Target at $53.00
Shares of Dianthus Therapeutics, Inc. (NASDAQ:DNTH – Get Free Report) have received an average recommendation of “Buy” from the nine ratings firms that are covering the firm, MarketBeat Ratings reports. Seven investment analysts have rated the stock with a buy rating and two have assigned a strong buy rating to the company. The average 12-month […]
Shares of Dianthus Therapeutics, Inc. (NASDAQ:DNTH – Get Free Report) have received an average recommendation of “Buy” from the nine ratings firms that are covering the firm, MarketBeat Ratings reports. Seven investment analysts have rated the stock with a buy rating and two have assigned a strong buy rating to the company. The average 12-month […]
